The purpose of this study is to describe clinical and demographic characteristics of patients
receiving prescription medications containing oxycodone immediate release (OXYRX), to
characterize patient and prescriber perceptions of the effectiveness outcomes and
tolerability of OXYRX treatment, to describe prescriber decision-making about pain management
with a Schedule II opioid and to explore how prescribers identify suspected abuse of pain
medications.